Verismo Selects Zer0 to 5ive for Messaging, Website and PR

Verismo, a pioneer in CAR T-cell therapy for the treatment of solid tumors, has selected Zer0 to 5ive to help it refine its messaging, develop a new website and handle its public relations. The spinoff from Penn has developed a unique approach to treating solid tumors through the creation of the first multi-chain CAR T construct.